iShares^®

iShares Trust

iShares, Inc.

(each, a “Company”)

Supplement dated November 20, 2009

to the Prospectuses and Statements of Additional

Information (“SAI”) for all series of iShares Trust

and iShares, Inc.

The information in this Supplement updates information in, and should be read in conjunction with, each Prospectus and SAI as supplemented.

Barclays Global Fund Advisors (the “Adviser”) serves as the investment adviser for each iShares fund (each, a “Fund”). On June 16, 2009, Barclays PLC (“Barclays”), the ultimate parent company of the Adviser, accepted a binding offer and entered into an agreement to sell its interests in the Adviser and certain affiliated companies to BlackRock, Inc. (the “Transaction”).

Under the Investment Company Act of 1940, as amended, completion of the Transaction will cause the automatic termination of each Fund’s current investment advisory agreement with the Adviser. In order for the management of each Fund to continue uninterrupted, each Fund’s Board of Trustees or Directors (the “Board”) approved a new investment advisory agreement. On November 4, 2009, two special meetings of shareholders of the Funds were called: 1) a meeting to consider the approval of the new investment advisory agreement and a certain other proposal (the “First Special Meeting”); and 2) a separate meeting to elect a Board of each Company (the “Second Special Meeting”). For certain Funds, the First Special Meeting was adjourned until November 19, 2009, and at that date, the First Special Meeting was further adjourned for certain Funds identified below (the “Adjourned Funds”) until November 30, 2009 at 5:00 p.m. (Pacific Time). The Second Special Meeting was held and concluded for each Company on November 4, 2009. The results of those special meetings of shareholders are described below.

1) At the First Special Meeting of shareholders on November 4, 2009 until November 19, 2009, or as adjourned, shareholders of record as of August 25, 2009 (the “Record Date”) of each Fund (except for the Adjourned Funds) approved a new investment advisory agreement between the respective Company, on behalf of each of the Funds, and the Adviser, which will take effect upon the consummation of the Transaction.

2) At the First Special Meeting of shareholders on November 4, 2009 until November 19, 2009, or as adjourned, shareholders as of the Record Date of the Funds listed below approved a change in the

classification of each Fund’s investment objective from a fundamental investment policy to a non-fundamental investment policy. Accordingly, each Fund’s investment objective may, in the future, be changed without shareholder approval. Any reference to the contrary in each such Fund’s Prospectus or SAI is hereby deleted.

iShares Dow Jones U.S. Index Fund iShares Russell 1000 Index Fund iShares Russell Midcap Growth
Index Fund iShares Russell Midcap Index Fund iShares S&P 500 Index Fund iShares S&P Global Energy Sector Index Fund iShares S&P Global Healthcare Sector Index Fund iShares S&P Global Technology Sector Index Fund iShares S&P MidCap 400 Index Fund iShares S&P SmallCap 600 Growth Index Fund iShares S&P North American Technology-Multimedia Networking Index Fund iShares S&P North American Natural Resources Sector Index Fund iShares MSCI Australia Index Fund iShares MSCI Canada Index Fund iShares MSCI France Index Fund iShares MSCI Hong Kong Index Fund iShares MSCI Japan Index Fund iShares MSCI Malaysia Index Fund iShares MSCI Singapore Index Fund iShares MSCI Spain Index Fund iShares MSCI Switzerland Index Fund iShares MSCI Taiwan Index Fund iShares MSCI United Kingdom Index Fund

3) At the Second Special Meeting, shareholders as of the Record Date of each Company approved the election of each of the nominees to serve on the Board of Trustees and Directors. With the exception of Mr. Robert Kapito, each Trustee’s/Director’s term of office commenced immediately upon their election at the November 4, 2009 special meeting of shareholders. Mr. Kapito’s term of office will commence only upon the consummation of the Transaction.

4) The First Special Meeting of shareholders of the Adjourned Funds listed below has been adjourned until November 30, 2009, at 5:00 p.m. (Pacific Time).

iShares, Inc.
iShares MSCI Brazil Index Fund iShares MSCI EMU Index Fund iShares MSCI Germany Index Fund	iShares MSCI Mexico Investable Market Index Fund iShares MSCI Pacific ex-Japan Index Fund iShares MSCI South Korea Index Fund
iShares Trust
iShares S&P Europe 350 Index Fund iShares S&P Global 100 Index Fund iShares S&P Global Consumer Discretionary Sector Index Fund iShares S&P Global Consumer Staples Sector Index Fund iShares S&P Global Financials Sector Index Fund	iShares S&P Global Industrials Sector Index Fund iShares Dow Jones U.S. Medical Devices Index Fund iShares FTSE China (HK Listed) Index Fund iShares FTSE/Xinhua China 25 Index Fund

5) The Funds listed below commenced operations after the Record Date (the “New Funds”). As a result, shareholders were not entitled to notice of and to vote at the special meetings of shareholders meetings. Prior to the commencement of operations, the Board of Trustees or Directors and the sole shareholder of each New Fund approved a new investment advisory agreement between the respective Company, on behalf of each of the New Funds, and the Adviser. The new investment advisory agreement will take effect upon the consummation of the Transaction. Since the shareholders as of the Record Date of each Company approved the election of each of the nominees to serve on the Board of Trustees and Directors, the New Funds will also be overseen by the elected Trustees and Directors.

iShares 10+ Year Credit Bond Fund iShares MSCI Emerging Markets Eastern Europe Index Fund iShares Russell Top 200 Growth Index Fund iShares S&P India Nifty 50 Index Fund iShares 10+ Year Government/Credit Bond Fund iShares Russell Top 200 Index Fund iShares Russell Top 200 Value Index Fund

If you have any additional questions, please call 1-800-iShares (1-800-474-2737).

iShares^® is a registered trademark of Barclays Global Investors, N.A. BGI-A-ALL5-1109

PLEASE RETAIN THIS SUPPLEMENT

FOR FUTURE REFERENCE